These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3179449)

  • 1. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
    Price CM; Rassool F; Shivji MK; Gow J; Tew CJ; Haworth C; Goldman JM; Wiedemann LM
    Blood; 1988 Nov; 72(5):1829-32. PubMed ID: 3179449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
    Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
    Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(9;9)(p13;q34) in Philadelphia-negative chronic myeloid leukemia with breakpoint cluster region rearrangement.
    Sessarego M; Mareni C; Vimercati R; Defferrari R; Origone P; Damasio E; Ajmar F
    Cancer Genet Cytogenet; 1989 Nov; 43(1):51-6. PubMed ID: 2790772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
    Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
    Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
    Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
    Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
    Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
    Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
    Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
    J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities in CML.
    Hagemeijer A
    Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia with unusual variant Ph translocation (22;22)(q11;q13). Two cases with chimeric BCR-ABL transcripts.
    Laï JL; Aissaoui Z; Collyn-d'Hooghe C; Delfau MH; Grandchamp B; Fenaux P; Jouet JP; Desablens B; Deminatti M; Loucheux-Lefebvre MH
    Cancer Genet Cytogenet; 1990 Sep; 48(2):209-16. PubMed ID: 2204477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
    Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
    Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemia.
    Browett PJ; Cooke HM; Secker-Walker LM; Norton JD
    Cancer Genet Cytogenet; 1989 Feb; 37(2):169-77. PubMed ID: 2649233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.